RecallHawk

FLUTICASONE PROPIONATE ALLERGY RELIEF (FLUTICASONE PROPIONATE)

GLENMARK SPECLT

Summary

FDA approved FLUTICASONE PROPIONATE ALLERGY RELIEF (FLUTICASONE PROPIONATE) by GLENMARK SPECLT. ANDA (Generic) approval on 2026-03-16. SPRAY, METERED, NASAL.

Details

Source

Drug Approval

External ID

ANDA218742-1

Action Date

2026-03-16

Status

Approved

Category

drug

Product Code

ANDA (Generic)

Product Description

FLUTICASONE PROPIONATE ALLERGY RELIEF (generic: FLUTICASONE PROPIONATE), SPRAY, METERED, NASAL. Application: ANDA218742

Context & Analysis

GLENMARK SPECLT has 8 FDA actions in our database.

Frequently Asked Questions

How often does GLENMARK SPECLT have FDA actions?

GLENMARK SPECLT has 8 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "ANDA218742-1" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions